EC Number |
Source Tissue |
Reference |
---|
3.4.24.87 | A-498 cell |
a renal carcinoma cell line |
713189 |
3.4.24.87 | adrenal gland |
- |
679396 |
3.4.24.87 | astrocyte |
in cerebral corpora amylacea, that occur in aging brains and in patients with neurodegenerative conditions |
713116 |
3.4.24.87 | blood |
- |
650725, 680056, 711576 |
3.4.24.87 | blood |
cord blood. Neonates and children have a percentage ADANTS-13 activity similar to adults. 28/38 newborns have percentage activity within the normal range of healthy adults, 10 have significantly lower percentage activity that normalizes by day 2-3 |
670053 |
3.4.24.87 | blood plasma |
- |
650714, 669524, 670946, 677437, 678918, 678919, 678921, 678964, 678966, 679396, 680535, 680695, 680929, 681662, 681663, 682523, 682901, 682939, 719761, 719881, 720345, 720367, 735022, 735184, 754522, 755525, 755580, 755582, 755613, 755614 |
3.4.24.87 | blood plasma |
ADAMTS-13 activity in type 1, 2A, and 2B von Willebrand disease is higher than in healthy controls, but lower than in type 3 von Willebrand disease |
670948 |
3.4.24.87 | blood plasma |
ADAMTS13 activity decreases in a time-dependent manner during systemic inflammation |
670936 |
3.4.24.87 | blood plasma |
levels of ADAMTS13 are lower and levels of von Willebrand Factor are higher in young patients with cardiovascular disease compared to healthy individuals |
695967 |
3.4.24.87 | blood plasma |
no severe ADAMTS13 deficiency is detected in patients with sickle cell disease |
667122 |